Colonization of Germ-free Transgenic Mice with Genotyped Helicobacter pylori Strains from a Case-Control Study of Gastric Cancer Reveals a Correlation between Host Responses and HsdS Components of Type I Restriction-Modification Systems

Posted by: | August 17, 2023 | Comments


Helicobacter pylori infects the stomachs of half of all humans. It has a relatively benign relationship with most hosts but produces severe pathology, including gastric cancer, in others. Identifying the relative contributions of host, microbial, and environmental factors to the outcome of infection has been challenging. Here we describe one approach for identifying microbial genes that affect the magnitude of host responses to infection. Single colony purified H. pylori isolates were obtained from 25 cases and 71 controls in a Swedish case-control study of gastric cancer. Strains were first phenotyped based on their ability to produce adhesins that recognize two classes of human gastric epithelial receptors. Thirteen binding strains and two non-binding controls were then subjected to whole genome genotyping using H. pylori DNA microarrays. A cohort of “variable” genes was identified based on a microarray-determined call of “absent” in at least one member of the strain panel. Each strain was subsequently introduced into two types of germ-free transgenic mice, each programmed to express a different host factor postulated to pose increased risk for development of severe pathology.

Read more at: The Journal of Biological Chemistry

Britta M. Björkholm, Janaki L. Guruge, Jung D. Oh, Andrew J. Syder, Nina Salama, Karen Guillemin, Stanley Falkow, Christina Nilsson, Per G. Falk, Lars Engstrand, and Jeffrey I. Gordon. The Journal of Biological Chemistry. DOI: 10.1074/jbc.M203613200. 8 July 2023.

Stay up-to-date!
Email Address *
First Name
Last Name

* indicates required
Privacy Policy

Terms & Conditions | Privacy Policy | © 2021 The Translational Microbiome Research Forum

As of 3/31 the forum will no longer be active. Please visit for future bioscience events as Taconic remains committed to leading the industry in microbiome solutions. Thank you for your support.